IS4311A - Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra - Google Patents

Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra

Info

Publication number
IS4311A
IS4311A IS4311A IS4311A IS4311A IS 4311 A IS4311 A IS 4311A IS 4311 A IS4311 A IS 4311A IS 4311 A IS4311 A IS 4311A IS 4311 A IS4311 A IS 4311A
Authority
IS
Iceland
Prior art keywords
imidazole
substituted
preparation
Prior art date
Application number
IS4311A
Other languages
English (en)
Inventor
Geerts Jean-Pierre
Motte Geneviève
Differding Edmond
Henichart Jean-Pierre
Original Assignee
Ucb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb filed Critical Ucb
Publication of IS4311A publication Critical patent/IS4311A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS4311A 1994-12-14 1995-12-08 Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra IS4311A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9425211.1A GB9425211D0 (en) 1994-12-14 1994-12-14 Substituted 1H-imidazoles

Publications (1)

Publication Number Publication Date
IS4311A true IS4311A (is) 1996-06-15

Family

ID=10765918

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4311A IS4311A (is) 1994-12-14 1995-12-08 Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra

Country Status (26)

Country Link
US (1) US5658938A (is)
EP (1) EP0717037A1 (is)
JP (1) JPH08208622A (is)
KR (1) KR960022474A (is)
CN (1) CN1054376C (is)
AR (1) AR002257A1 (is)
AU (1) AU693614B2 (is)
BG (1) BG63043B1 (is)
BR (1) BR9505815A (is)
CA (1) CA2165133A1 (is)
CZ (1) CZ327195A3 (is)
EE (1) EE9500064A (is)
FI (1) FI955927A (is)
GB (1) GB9425211D0 (is)
HU (1) HUT73980A (is)
IL (1) IL116325A (is)
IS (1) IS4311A (is)
MX (1) MX9505063A (is)
NO (1) NO305316B1 (is)
NZ (1) NZ280646A (is)
PL (1) PL311736A1 (is)
RO (1) RO113346B1 (is)
RU (1) RU2156239C2 (is)
SK (1) SK155095A3 (is)
TW (1) TW303362B (is)
ZA (1) ZA9510554B (is)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
ZA981080B (en) * 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US20030073850A1 (en) * 1998-08-07 2003-04-17 Altenbach Robert J. 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
CA2408290A1 (en) 2000-05-08 2001-11-15 Orion Corporation New polycyclic indanylimidazoles with alpha2 adrenergic activity
TW200930291A (en) * 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
US20040266776A1 (en) * 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
EP1981499A1 (en) * 2006-01-27 2008-10-22 F.Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of cns disorders
ES2381589T3 (es) * 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
EP2076496B1 (en) * 2006-10-19 2010-03-31 F. Hoffmann-Roche AG Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
WO2008052907A1 (en) * 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles as modulators of the trace amine associated receptors
RU2456281C2 (ru) * 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
AU2007332641A1 (en) * 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (TAAR)
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
RU2473545C2 (ru) * 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
CA2678069A1 (en) * 2007-02-13 2008-08-21 Schering Corporation Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
CA2678036A1 (en) * 2007-02-13 2008-08-21 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
CL2008000431A1 (es) * 2007-02-13 2008-08-18 Schering Corp Compuestos derivados de biciclos o heterociclos condensados; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar afecciones relacionadas con los a2c adrenegicos, tales como congestion relacionada con rinitis, polipos o re
RU2460725C2 (ru) * 2007-02-15 2012-09-10 Ф. Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1
MX2009013742A (es) 2007-07-02 2010-01-26 Hoffmann La Roche 2-imidazolinas.
AU2008270444A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
RU2010104632A (ru) * 2007-07-27 2011-09-20 Ф.Хоффманн-Ля Рош Аг (Ch) 2-азетидинметанамины и 2-пирролидинметанамины в качестве лигандов taar
BRPI0815038A2 (pt) * 2007-08-02 2015-03-17 Hoffmann La Roche Uso de derivados de benzamida para o tratamento de transtornos do cns
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
US8383818B2 (en) 2008-02-21 2013-02-26 Merck Sharp & Dohme Corp. Functionally selective alpha2C adrenoreceptor agonists
WO2010010014A1 (en) * 2008-07-24 2010-01-28 F. Hoffmann-La Roche Ag 4,5-dihydro-oxazol-2-yl derivatives
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
EP2323734A1 (en) * 2008-08-04 2011-05-25 Schering Corporation Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
TW201026691A (en) 2008-10-07 2010-07-16 Schering Corp Biaryl spiroaminooxazoline analogues as alpha2C adrenergic receptor modulators
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
US8802673B2 (en) 2011-03-24 2014-08-12 Hoffmann-La Roche Inc Heterocyclic amine derivatives
US9073911B2 (en) 2011-06-09 2015-07-07 Hoffmann-La Roche Inc. Pyrazole derivatives
US9029370B2 (en) 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
WO2013104591A1 (en) 2012-01-12 2013-07-18 F. Hoffmann-La Roche Ag Heterocyclic derivatives as trace amine associated receptors (taars)
MY178667A (en) 2012-09-14 2020-10-20 Hoffmann La Roche Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease
MX361761B (es) 2012-09-17 2018-12-17 Hoffmann La Roche Derivados de triazol carboxamida.
WO2015165085A1 (en) 2014-04-30 2015-11-05 F.Hoffmann-La Roche Ag Morpholin-pyridine derivatives
BR112017000160A2 (pt) 2014-08-27 2017-10-31 Hoffmann La Roche derivados de azetidina substituidos como ligantes de taar
CN106470994B (zh) 2014-08-27 2019-09-24 豪夫迈·罗氏有限公司 用于治疗cns疾病的取代的吡嗪并[2,1-a]异喹啉衍生物
EP3560911B1 (en) * 2016-03-17 2021-05-05 FMC Corporation Process for converting s-enantiomer to its racemic form
RU2731095C2 (ru) 2016-03-17 2020-08-28 Ф. Хоффманн-Ля Рош Аг Производное 5-этил-4-метил-пиразол-3-карбоксамида, обладающее активностью агониста taar

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048972A (ja) * 1983-08-25 1985-03-16 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5151526A (en) * 1990-10-11 1992-09-29 The United States Of America As Represented By The Secretary Of The Army 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic
JPH04210680A (ja) * 1990-12-01 1992-07-31 Nissan Chem Ind Ltd イミダゾール誘導体および植物生長調節剤
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles

Also Published As

Publication number Publication date
NZ280646A (en) 1996-08-27
NO305316B1 (no) 1999-05-10
IL116325A0 (en) 1996-03-31
NO955034D0 (no) 1995-12-12
PL311736A1 (en) 1996-06-24
EP0717037A1 (fr) 1996-06-19
KR960022474A (ko) 1996-07-18
ZA9510554B (en) 1996-06-13
AU4036895A (en) 1996-06-20
AU693614B2 (en) 1998-07-02
CN1054376C (zh) 2000-07-12
IL116325A (en) 1999-10-28
HUT73980A (en) 1996-10-28
RU2156239C2 (ru) 2000-09-20
HU9503549D0 (en) 1996-02-28
CA2165133A1 (en) 1996-06-15
BG63043B1 (bg) 2001-02-28
NO955034L (no) 1996-06-17
GB9425211D0 (en) 1995-02-15
FI955927A (fi) 1996-06-15
MX9505063A (es) 1997-01-31
US5658938A (en) 1997-08-19
FI955927A0 (fi) 1995-12-11
SK155095A3 (en) 1997-02-05
BG100208A (bg) 1996-07-31
TW303362B (is) 1997-04-21
BR9505815A (pt) 1998-01-06
EE9500064A (et) 1996-06-17
CZ327195A3 (en) 1996-07-17
AR002257A1 (es) 1998-03-11
CN1133837A (zh) 1996-10-23
RO113346B1 (ro) 1998-06-30
JPH08208622A (ja) 1996-08-13

Similar Documents

Publication Publication Date Title
IS4311A (is) Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra
NO20012774L (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
NO964217D0 (no) Fremgangsmåte og anordning relatert til telekommunikasjonssystemer
NO972687L (no) Utskyllingslösning og fremgangsmåte for inhibering av smerte, inflammasjon og spasmer
DK0799052T3 (da) Ny antihrombotisk formulering, fremgangsmåde til dens fremstilling og anvendelse deraf
DK0736926T3 (da) Elastisk antennestruktur og fremgangsmåde til fremstilling
DK1041879T4 (da) Desinfektionsmiddel og fremstillingsmetode
DK0664300T3 (da) Pectin, fremgangsmåde og sammensætning
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
NO992297D0 (no) FremgangsmÕte og nye forbindelser
DK0656176T3 (da) Pectin, fremgangsmåde og sammensætning
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
IS1968B (is) Tilbúnar fjölsykrur, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
DK0702344T3 (da) Etiketkontinuum og fremgangsmåde til fremstilling deraf
NO980257D0 (no) Forankringsinnretning, og fremgangsmåte ved forankring
FI972783A0 (fi) Järjestelmä ja menetelmä liittyen langattomaan viestintään
EE9900141A (et) Keerdotstega suletav pakend ja meetod pakendamiseks
DK0732276T3 (da) Spraydåse og fremgangsmåde til dens fremstilling
PL331287A1 (en) Substituted derivatives of pyrazoyl-pyrazole, method of obtaining them and their application as herbicides
DK0512547T3 (da) Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
PL320360A1 (en) Iminoxymethylene anilides, method of obtaining them and their application
IS4035A (is) Benzodiazepinesefni, aðferð til framleiðslu þeirra og notkunar sem lyfja
PL325142A1 (en) Novel compounds-derivatives of benzoxazinodione, method of obtaining them and their application
FR2750134B1 (fr) 1-c-perfluoroalkyl glycosides, procede de preparation et utilisations
NO961931L (no) Isolasjonsblokk og fremgangsmåte til fremstilling og anvendelse derav